1887

Microbiology Society logo

Volume 159, Issue Pt_4

clinical isolates identified as tetracycline resistant do not exhibit resistance : whole-genome sequencing reveals a mutation in but no evidence for tetracycline resistance genes Free

Abstract

is the most common bacterial sexually transmitted infection worldwide and the leading cause of preventable blindness in developing countries. Tetracycline is commonly the drug of choice for treating infections, but cases of antibiotic resistance in clinical isolates have previously been reported. Here, we used antibiotic resistance assays and whole-genome sequencing to interrogate the hypothesis that two clinical isolates (IU824 and IU888) have acquired mechanisms of antibiotic resistance. Immunofluorescence staining was used to identify inclusions in cell cultures grown in the presence of tetracycline; however, only antibiotic-free control cultures yielded the strong fluorescence associated with the presence of chlamydial inclusions. Infectivity was lost upon passage of harvested cultures grown in the presence of tetracycline into antibiotic-free medium, so we conclude that these isolates were phenotypically sensitive to tetracycline. Comparisons of the genome and plasmid sequences for the two isolates with tetracycline-sensitive strains did not identify regions of low sequence identity that could accommodate horizontally acquired resistance genes, and the tetracycline binding region of the 16S rRNA gene was identical to that of the sensitive control strains. The gene of strain IU824, however, was found to contain a premature stop codon not previously identified, which is noteworthy but unlikely to be related to tetracycline resistance. In conclusion, we found no evidence of tetracycline resistance in the two strains investigated, and it seems most likely that the small, aberrant inclusions previously identified resulted from the high chlamydial load used in the original antibiotic resistance assays.

  • Received:
  • Accepted:
  • Revised:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.065391-0
2013-04-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/micro/159/4/748.html?itemId=/content/journal/micro/10.1099/mic.0.065391-0&mimeType=html&fmt=ahah

References

  1. Andersson S. G., Alsmark C., Canbäck B., Davids W., Frank C., Karlberg O., Klasson L., Antoine-Legault B., Mira A., Tamas I. ( 2002). Comparative genomics of microbial pathogens and symbionts. Bioinformatics 18:Suppl. 2S17 [View Article] [PubMed]
     [Google Scholar]
  2. Assefa S., Keane T. M., Otto T. D., Newbold C., Berriman M. ( 2009). abacas: algorithm-based automatic contiguation of assembled sequences. Bioinformatics 25:1968–1969 [View Article] [PubMed]
     [Google Scholar]
  3. Bordenstein S. R., Reznikoff W. S. ( 2005). Mobile DNA in obligate intracellular bacteria. Nat Rev Microbiol 3:688–699 [View Article] [PubMed]
     [Google Scholar]
  4. Brodersen D. E., Clemons W. M. Jr, Carter A. P., Morgan-Warren R. J., Wimberly B. T., Ramakrishnan V. ( 2000). The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell 103:1143–1154 [View Article] [PubMed]
     [Google Scholar]
  5. Brook I. ( 1989). Inoculum effect. Rev Infect Dis 11:361–368 [View Article] [PubMed]
     [Google Scholar]
  6. Carver T. J., Rutherford K. M., Berriman M., Rajandream M. A., Barrell B. G., Parkhill J. ( 2005). ACT: the Artemis Comparison Tool. Bioinformatics 21:3422–3423 [View Article] [PubMed]
     [Google Scholar]
  7. Cromwell G. L. ( 2002). Why and how antibiotics are used in swine production. Anim Biotechnol 13:7–27 [View Article] [PubMed]
     [Google Scholar]
  8. Donati M., Di Francesco A., D’Antuono A., Delucca F., Shurdhi A., Moroni A., Baldelli R., Cevenini R. ( 2010). In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K. Antimicrob Agents Chemother 54:5379–5380 [View Article] [PubMed]
     [Google Scholar]
  9. Dugan J., Rockey D. D., Jones L., Andersen A. A. ( 2004). Tetracycline resistance in Chlamydia suis mediated by genomic islands inserted into the chlamydial inv-like gene. Antimicrob Agents Chemother 48:3989–3995 [View Article] [PubMed]
     [Google Scholar]
  10. Enne V. I., Bennett P. M. ( 2010). Methods to determine antibiotic resistance gene silencing. Methods Mol Biol 642:29–44 [View Article] [PubMed]
     [Google Scholar]
  11. Enne V. I., Delsol A. A., Roe J. M., Bennett P. M. ( 2006). Evidence of antibiotic resistance gene silencing in Escherichia coli . Antimicrob Agents Chemother 50:3003–3010 [View Article] [PubMed]
     [Google Scholar]
  12. Finan J. E., Rosato A. E., Dickinson T. M., Ko D., Archer G. L. ( 2002). Conversion of oxacillin-resistant staphylococci from heterotypic to homotypic resistance expression. Antimicrob Agents Chemother 46:24–30 [View Article] [PubMed]
     [Google Scholar]
  13. Gerrits M. M., de Zoete M. R., Arents N. L., Kuipers E. J., Kusters J. G. ( 2002). 16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori . Antimicrob Agents Chemother 46:2996–3000 [View Article] [PubMed]
     [Google Scholar]
  14. Harris S. R., Clarke I. N., Seth-Smith H. M., Solomon A. W., Cutcliffe L. T., Marsh P., Skilton R. J., Holland M. J., Mabey D. & other authors ( 2012). Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet 44:413–419, S1 [View Article] [PubMed]
     [Google Scholar]
  15. Jones R. B., Van der Pol B., Martin D. H., Shepard M. K. ( 1990). Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics. J Infect Dis 162:1309–1315 [View Article] [PubMed]
     [Google Scholar]
  16. Kang C. I., Pai H., Kim S. H., Kim H. B., Kim E. C., Oh M. D., Choe K. W. ( 2004). Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase. J Antimicrob Chemother 54:1130–1133 [View Article] [PubMed]
     [Google Scholar]
  17. Kenny G. E., Hooton T. M., Roberts M. C., Cartwright F. D., Hoyt J. ( 1989). Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method. Antimicrob Agents Chemother 33:103–107 [View Article] [PubMed]
     [Google Scholar]
  18. Kubo A., Stephens R. S. ( 2000). Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target. Mol Microbiol 38:772–780 [View Article] [PubMed]
     [Google Scholar]
  19. Kubo A., Stephens R. S. ( 2001). Substrate-specific diffusion of select dicarboxylates through Chlamydia trachomatis PorB. Microbiology 147:3135–3140 [PubMed]
     [Google Scholar]
  20. LaPlante K. L., Rybak M. J. ( 2004). Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 48:4665–4672 [View Article] [PubMed]
     [Google Scholar]
  21. Lefevre J. C., Lepargneur J. P., Guion D., Bei S. ( 1997). Tetracycline-resistant Chlamydia trachomatis in Toulouse, France. Pathol Biol (Paris) 45:376–378 [PubMed]
     [Google Scholar]
  22. Lenart J., Andersen A. A., Rockey D. D. ( 2001). Growth and development of tetracycline-resistant Chlamydia suis . Antimicrob Agents Chemother 45:2198–2203 [View Article] [PubMed]
     [Google Scholar]
  23. Milch R. A., Rall D. P., Tobie J. E. ( 1958). Fluorescence of tetracycline antibiotics in bone. J Bone Joint Surg Am 40-A:897–910 [PubMed]
     [Google Scholar]
  24. Misyurina O. Y., Chipitsyna E. V., Finashutina Y. P., Lazarev V. N., Akopian T. A., Savicheva A. M., Govorun V. M. ( 2004). Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides. Antimicrob Agents Chemother 48:1347–1349 [View Article] [PubMed]
     [Google Scholar]
  25. Pantchev A., Sting R., Bauerfeind R., Tyczka J., Sachse K. ( 2010). Detection of all Chlamydophila and Chlamydia spp. of veterinary interest using species-specific real-time PCR assays. Comp Immunol Microbiol Infect Dis 33:473–484 [View Article] [PubMed]
     [Google Scholar]
  26. Roblin P. M., Hammerschlag M. R. ( 2000). In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis . Int J Antimicrob Agents 16:61–63 [View Article] [PubMed]
     [Google Scholar]
  27. Ross J. I., Eady E. A., Cove J. H., Cunliffe W. J. ( 1998). 16S rRNA mutation associated with tetracycline resistance in a Gram-positive bacterium. Antimicrob Agents Chemother 42:1702–1705 [PubMed]
     [Google Scholar]
  28. Rutherford K., Parkhill J., Crook J., Horsnell T., Rice P., Rajandream M. A., Barrell B. ( 2000). Artemis: sequence visualization and annotation. Bioinformatics 16:944–945 [View Article] [PubMed]
     [Google Scholar]
  29. Sandoz K. M., Rockey D. D. ( 2010). Antibiotic resistance in Chlamydiae. Future Microbiol 5:1427–1442 [View Article] [PubMed]
     [Google Scholar]
  30. Seth-Smith H. M. B., Harris S. R., Persson K., Marsh P., Barron A., Bignell A., Bjartling C., Clark L., Cutcliffe L. T. & other authors ( 2009). Co-evolution of genomes and plasmids within Chlamydia trachomatis and the emergence in Sweden of a new variant strain. BMC Genomics 10:239 [View Article] [PubMed]
     [Google Scholar]
  31. Skilton R. J., Cutcliffe L. T., Pickett M. A., Lambden P. R., Fane B. A., Clarke I. N. ( 2007). Intracellular parasitism of chlamydiae: specific infectivity of chlamydiaphage Chp2 in Chlamydophila abortus . J Bacteriol 189:4957–4959 [View Article] [PubMed]
     [Google Scholar]
  32. Skilton R. J., Cutcliffe L. T., Barlow D., Wang Y., Salim O., Lambden P. R., Clarke I. N. ( 2009). Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the developmental cycle. PLoS ONE 4:e7723 [View Article] [PubMed]
     [Google Scholar]
  33. Solomon A. W., Mohammed Z., Massae P. A., Shao J. F., Foster A., Mabey D. C., Peeling R. W. ( 2005). Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis . Antimicrob Agents Chemother 49:4804–4806 [View Article] [PubMed]
     [Google Scholar]
  34. Stephens R. S., Kalman S., Lammel C., Fan J., Marathe R., Aravind L., Mitchell W., Olinger L., Tatusov R. L. & other authors ( 1998). Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis . Science 282:754–759 [View Article] [PubMed]
     [Google Scholar]
  35. Suchland R. J., Sandoz K. M., Jeffrey B. M., Stamm W. E., Rockey D. D. ( 2009). Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro. Antimicrob Agents Chemother 53:4604–4611 [View Article] [PubMed]
     [Google Scholar]
  36. Thomson N. R., Holden M. T. G., Carder C., Lennard N., Lockey S. J., Marsh P., Skipp P., O’Connor C. D., Goodhead I. & other authors ( 2008). Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates. Genome Res 18:161–171 [View Article] [PubMed]
     [Google Scholar]
  37. Unemo M., Seth-Smith H. M., Cutcliffe L. T., Skilton R. J., Barlow D., Goulding D., Persson K., Harris S. R., Kelly A. & other authors ( 2010). The Swedish new variant of Chlamydia trachomatis: genome sequence, morphology, cell tropism and phenotypic characterization. Microbiology 156:1394–1404 [View Article] [PubMed]
     [Google Scholar]
  38. van Hoek A. H., Mevius D., Guerra B., Mullany P., Roberts A. P., Aarts H. J. ( 2011). Acquired antibiotic resistance genes: an overview. Front Microbiol 2:203 [PubMed] [CrossRef]
     [Google Scholar]
  39. Vester B., Douthwaite S. ( 2001). Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother 45:1–12 [View Article] [PubMed]
     [Google Scholar]
  40. Wang S. A., Papp J. R., Stamm W. E., Peeling R. W., Martin D. H., Holmes K. K. ( 2005). Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J Infect Dis 191:917–923 [View Article] [PubMed]
     [Google Scholar]
  41. Wang Y., Kahane S., Cutcliffe L. T., Skilton R. J., Lambden P. R., Clarke I. N. ( 2011). Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog 7:e1002258 [View Article] [PubMed]
     [Google Scholar]
  42. Wyrick P. B., Knight S. T. ( 2004). Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin. J Antimicrob Chemother 54:79–85 [View Article] [PubMed]
     [Google Scholar]
  43. Zerbino D. R., Birney E. ( 2008). Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18:821–829 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.065391-0
Loading
Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes
Microbiology 159, 748 (2013); https://doi.org/10.1099/mic.0.065391-0
/content/journal/micro/10.1099/mic.0.065391-0
/content/journal/micro/10.1099/mic.0.065391-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error